Extract from the Register of European Patents

EP About this file: EP2948436

EP2948436 - NOVEL TRAPS IN THE TREATMENT OF MACULAR DEGENERATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  14.02.2020
Database last updated on 11.04.2026
FormerGrant of patent is intended
Status updated on  13.05.2019
FormerExamination is in progress
Status updated on  02.06.2017
Most recent event   Tooltip14.02.2020Application deemed to be withdrawnpublished on 18.03.2020  [2020/12]
Applicant(s)For all designated states
Aldeyra Therapeutics, Inc.
131 Hartwell Avenue
Suite 320
Lexington, MA 02421 / US
[2015/49]
Inventor(s)01 / CHABALA, John, Clifford
221 Throwbridge Drive
Scotch Plains, NJ 07076 / US
02 / JORDAN, Thomas, A.
12214 Main Campus Drive
Lexington, MA 02421 / US
03 / LING, Ke-Qing
7258 Auburn Road
Painesville, OH 44077 / US
04 / GLEASON, John, G.
2296 Cleawater Run
The Villages, FL 32162 / US
05 / KINNEY, William, A.
16 Thompson Mill Road
Newtown, PA 18940 / US
 [2015/49]
Representative(s)Tostmann, Holger Carl
Wallinger Ricker Schlotter Tostmann
Patent- und Rechtsanwälte Partnerschaft mbB
Zweibrückenstrasse 5-7
80331 München / DE
[N/P]
Former [2015/49]Tostmann, Holger Carl
Wallinger Ricker Schlotter Tostmann
Patent- und Rechtsanwälte
Zweibrückenstrasse 5-7
80331 München / DE
Application number, filing date14743787.521.01.2014
[2015/49]
WO2014US12356
Priority number, dateUS201361756778P25.01.2013         Original published format: US 201361756778 P
[2015/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2014116593
Date:31.07.2014
Language:EN
[2014/31]
Type: A1 Application with search report 
No.:EP2948436
Date:02.12.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 31.07.2014 takes the place of the publication of the European patent application.
[2015/49]
Search report(s)International search report - published on:KR31.07.2014
(Supplementary) European search report - dispatched on:EP14.06.2016
ClassificationIPC:C07D263/57, C07D263/54, A61K31/421, A61P27/00
[2015/49]
CPC:
A61K31/421 (EP,US); A61P27/00 (EP); A61P27/02 (EP);
A61P43/00 (EP); C07D261/20 (EP,US); C07D263/57 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/49]
TitleGerman:NEUARTIGE FALLEN BEI DER BEHANDLUNG VON MAKULADEGENERATION[2015/49]
English:NOVEL TRAPS IN THE TREATMENT OF MACULAR DEGENERATION[2015/49]
French:NOUVEAUX PIÈGES DANS LE TRAITEMENT DE LA DÉGÉNÉRESCENCE MACULAIRE[2015/49]
Entry into regional phase22.07.2015National basic fee paid 
22.07.2015Search fee paid 
22.07.2015Designation fee(s) paid 
22.07.2015Examination fee paid 
Examination procedure22.07.2015Examination requested  [2015/49]
09.01.2017Amendment by applicant (claims and/or description)
07.06.2017Despatch of a communication from the examining division (Time limit: M04)
10.10.2017Reply to a communication from the examining division
17.01.2018Despatch of a communication from the examining division (Time limit: M04)
24.05.2018Reply to a communication from the examining division
14.09.2018Despatch of a communication from the examining division (Time limit: M04)
16.01.2019Reply to a communication from the examining division
14.05.2019Communication of intention to grant the patent
25.09.2019Application deemed to be withdrawn, date of legal effect  [2020/12]
31.10.2019Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2020/12]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.06.2017
Fees paidRenewal fee
27.01.2016Renewal fee patent year 03
27.01.2017Renewal fee patent year 04
29.01.2018Renewal fee patent year 05
28.01.2019Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I] WO2006127945  (NEURON SYSTEMS et al.) [I] 1-13 * claims 1, 7, 32, 33 * * paragraph [000190] *
International search[X] US7973025  (JORDAN THOMAS A et al.) [X]
 [A] US2005020603  (DAI YUJIA et al.) [A]
 [A] US2006189608  (BINGAMAN DAVID P et al.) [A]
 [A] US2012108585  (VU CHI B et al.) [A]
by applicantWO2006127945
   SPARROW J. R. ET AL.: "Phospholipid meets all-trans-retinal: the making of RPE bisretinoids", J. LIPID RES., 7 August 2009 (2009-08-07)
   BURSTEIN, TRANS OPHTHALMOL SOC U K, vol. 104, 1985, pages 402 - 9
   ASHTON ET AL., J PHARMACOL EXP THER, vol. 259, no. 2, 1991, pages 719 - 24
   GREEN ET AL., AM J OPHTHALMOL, vol. 72, no. 5, 1971, pages 897 - 905
   TANG ET AL., J PHARM SCI, vol. 83, no. 1, 1994, pages 85 - 90
   BURSTEIN ET AL., INVEST OPHTHALMOL VIS SCI, vol. 19, no. 3, 1980, pages 308 - 13
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.